ARSArs Technica·5dHealth
score-0.30
DEA Schedule I Ban Raises Questions About Future Opioid Treatment Research
Original
The DEA banned a drug some opioid users called a miracle
“Highlights the potential loss of medical research and patient access due to regulatory action, conveying worry without alarmism.”